Skip to main content

Advertisement

SpringerLink
Log in

Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer

  • Letter to the Editor
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Pacini F, Brianzoni E, Durante C, Elisei R, Ferdeghini M, Fugazzola L, Mariotti S, Pellegriti G (2016) Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology. J Endocrinol Invest 39:341–347. doi:10.1007/s40618-015-0375-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E, European Association of Nuclear Medicine (EANM) (2008) Guidelines for radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 35:1941–1959. doi:10.1007/s00259-008-0883-1

    Article  CAS  PubMed  Google Scholar 

  3. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–133

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Humanitas University, via Manzoni, 113, Rozzano, 20089, Milan, Italy

    M. Sollini & A. Chiti

  2. Nuclear Medicine Department, Niguarda Hospital, Piazza Ospedale Maggiore, 3, 20162, Milan, Italy

    C. Rossetti

  3. Nuclear Medicine Department, Humanitas Research Hospital, via Manzoni, 113, Rozzano, 20089, Milan, Italy

    A. Chiti

Authors
  1. M. Sollini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Rossetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Chiti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Sollini.

Ethics declarations

Funding

None.

Conflict of interest

Martina Sollini Member of the EANM Drug Development Committee. Claudio Rossetti Member working group on radiopharmaceuticals AIFA (Italian regulatory). Mallinckrodt, travel grants. Arturo Chiti EANM President (2015–2016). He received support from the following pharmaceutical, device or biotechnology company: Lilly, travel grants. Genzyme, travel grants. Mallinckrodt, travel grants. Astrim, travel grants. Eckert & Ziegler, travel grants. IBA molecular, travel grants. IBSA, travel grants. GE Healthcare, travel grants, honorarium for scientific activities. Sirtex Medical Europe, honorarium for scientific activity. EISAI, payment of diagnostic procedures. Novartis, payment of diagnostic procedures. Seattle, payment of diagnostic procedures. Millennium, payment of diagnostic procedures. Exelixis, payment of diagnostic procedures. Bristol, payment of diagnostic procedures. Janssen, payment of diagnostic procedures. Bayer, payment of diagnostic procedures. Celgene, payment of diagnostic procedures.

Ethical approval

Not applicable (no human participants and/or animals involved).

Informed consent

For this type of study formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sollini, M., Rossetti, C. & Chiti, A. Comments on the Italian Society of Endocrinology recommendations on post-surgical thyroid ablation in differentiated thyroid cancer. J Endocrinol Invest 39, 485–486 (2016). https://doi.org/10.1007/s40618-016-0448-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-016-0448-2

Keywords

Search

Navigation